[18F]BIBD-181

N/A

Report date: 2025/11/24 11:49:44

NME

Base Information

Drug Name[18F]BIBD-181

Drug Alias Name[18F]BIBD-181

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agent +[5]

Mechanisms of ActionSynaptic vesicle glycoprotein 2A modulators

TargetsSynaptic vesicle glycoprotein 2A

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesCapital Medical University

China Registration ClassN/A

Develop Information

Active CompaniesCapital Medical University

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A